NEW YORK (GenomeWeb News) — Shares in CombiMatrix were down 7 percent at $.76 in mid-afternoon trading after the company this morning reported dismal fourth-quarter results.
 
As GenomeWeb News reported this morning, the Acacia unit said fourth-quarter revenues fell 76 percent and losses more than doubled year over year.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The New York Times profiles 23andMe's Anne Wojcicki and describes how she bounced back from a bad year.

Fotis Kafatos, the founding president of the European Research Council, has died, according to the Associated Press.

In PLOS this week: genomic analysis of honeybee disease, microRNA profiles of people with lupus nephritis, and more.

The Verge's Angela Chen tried out a gene test for fitness advice, but didn't learn much new information.